68 related articles for article (PubMed ID: 7945272)
1. Arrested development: understanding v-abl.
Kerr LD
Bioessays; 1994 Jul; 16(7):453-5. PubMed ID: 7945272
[TBL] [Abstract][Full Text] [Related]
2. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation.
Rosenberg N
Semin Cancer Biol; 1994 Apr; 5(2):95-102. PubMed ID: 8061334
[TBL] [Abstract][Full Text] [Related]
3. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
4. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
5. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
6. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
[TBL] [Abstract][Full Text] [Related]
7. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
8. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
9. Transforming activity and tissue tropism of hybrid retroviral genomes containing portions of the v-abl and v-src oncogenes.
Hevezi P; Alin K; Goff SP
Oncogene; 1993 Sep; 8(9):2413-23. PubMed ID: 8361756
[TBL] [Abstract][Full Text] [Related]
10. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
Keller JR; Ruscetti SK; Ruscetti FW
Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
[TBL] [Abstract][Full Text] [Related]
11. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.
Lam QL; Lo CK; Zheng BJ; Ko KH; Osmond DG; Wu GE; Rottapel R; Lu L
Int Immunol; 2007 Mar; 19(3):267-76. PubMed ID: 17229817
[TBL] [Abstract][Full Text] [Related]
12. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
Hines DL
Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
[TBL] [Abstract][Full Text] [Related]
13. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus.
Hevezi P; Alin K; Rees-Jones R; Goff SP
Oncogene; 1992 Nov; 7(11):2323-8. PubMed ID: 1437154
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of v-Abl transformation by p53 and p19ARF.
Cong F; Zou X; Hinrichs K; Calame K; Goff SP
Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
[TBL] [Abstract][Full Text] [Related]
18. BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential.
Ramakrishnan L; Wu Q; Yue A; Cooper MD; Rosenberg N
J Immunol; 1990 Sep; 145(5):1603-8. PubMed ID: 1974567
[TBL] [Abstract][Full Text] [Related]
19. c-fos is not essential for v-abl-induced lymphomagenesis.
Saez E; Oppenheim H; Smoluk J; Andersen JW; Van Etten RA; Spiegelman BM
Cancer Res; 1995 Dec; 55(24):6196-9. PubMed ID: 8521413
[TBL] [Abstract][Full Text] [Related]
20. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
